You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for preventing venous thromboembolism after hip or knee replacement surgery

  • Technology appraisal guidance
  • Reference number: TA170
  • Published:  22 April 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members, guideline representatives and NICE project team
  • 8 Sources of evidence considered by the Committee
  • 9 Update information

6 Recommendations for further research

6.1

Further head-to-head trials of rivaroxaban compared with enoxaparin and dabigatran in both total hip replacement and total knee replacement would be useful to strengthen the evidence base for this comparison.


Next page 7 Appraisal Committee members, guideline representatives and NICE project team Previous page 5 Implementation
Back to top